MDSCs can induce IL‐23 and Th17 generation, reduce the effects of IL‐12 and NK cells, and inhibit Th1 and IFN‐γ mediated anti‐tumor immunity, thus increasing the immunosuppression of the TME.55 This evidence concerns the gene IFNG and neoplasm.